Skip to Content

Health

2 Asian American senators back off threat to oppose Biden nominees after White House agrees to add senior AAPI adviser

Sens. Tammy Duckworth and Mazie Hirono on Tuesday backed off their threat to vote against any of President Joe Biden’s nominees who aren’t minorities, after going public with their anger that the Cabinet lacks Asian Americans, and Duckworth earlier saying she felt insulted by the White House’s attempts to brush off her concerns. The move

Continue Reading

Trial review board raises concerns about AstraZeneca vaccine data

In an unusual statement released early Tuesday, the National Institute of Allergy and Infectious Diseases said the independent board that reviews data from multiple Covid-19 vaccine candidates has raised concerns about AstraZeneca’s announcement of efficacy data from its vaccine trial. “The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which

Continue Reading

Fully vaccinated people can visit unvaccinated family and friends, but one household at a time, CDC official says

Fully vaccinated people should feel free to visit their unvaccinated family and friends without restrictions, but visits should be limited to one unvaccinated household at a time, Centers for Disease Control and Prevention officials said Monday. And sorry, but even fully vaccinated grandparents should not be bringing their grandkids to church or otherwise exposing them

Continue Reading

All the Covid-19 vaccines prevent death and severe disease, and that’s what matters, experts say

A fifth company — AstraZeneca — released data Monday about how well its coronavirus vaccine works and said it plans to ask the US Food and Drug Administration for emergency use authorization in the coming weeks. Drug giant AstraZeneca said Monday its vaccine, developed with Britain’s Oxford University, showed about 79% efficacy in preventing symptomatic

Continue Reading

AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says

AstraZeneca’s Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday. The findings from the new Phase 3 trial, which included more than 32,000 participants, may boost confidence in the vaccine, which was originally developed by the University of

Continue Reading